Qureight and Avalyn launch strategic partnership in progressive pulmonary fibrosis

Qureight and Avalyn launch strategic partnership in progressive pulmonary fibrosis

Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat life-threatening pulmonary diseases, have announced the initiation of a strategic partnership in progressive pulmonary fibrosis.

Paragraf and the University of Cambridge Receive Innovate UK Grant for Graphene Memory Device Initiative

Paragraf and the University of Cambridge Receive Innovate UK Grant for Graphene Memory Device Initiative

Paragraf, a UK-based company leading the way in mass-producing graphene-based electronics using standard semiconductor processes, has been awarded a £419,419 grant from Innovate UK.

The Five Biggest Challenges in Neuro Rehab Transitions

The Five Biggest Challenges in Neuro Rehab Transitions

Transitioning from acute care to outpatient therapy is a major milestone for stroke victims and others recovering from neurological issues. However, leaving the hospital behind introduces a new set of challenges for the patient that can be difficult to overcome.

Ubisense Appoints Kate Edge as New Chief Financial Officer

Ubisense Appoints Kate Edge as New Chief Financial Officer

Ubisense is pleased to announce the appointment of Kate Edge as its new Chief Financial Officer. With over 15 years of financial leadership experience across major industry players, Kate brings a wealth of expertise and a clear vision to drive Ubisense’s growth, profitability, and operational excellence.

Wilder Sensing secures £300,000 equity investment from South West Investment Fund

Wilder Sensing secures £300,000 equity investment from South West Investment Fund

Wilder Sensing, a Somerset-based developer of software for biodiversity monitoring using audio and artificial intelligence (AI), has secured a £300,000 equity investment from the South West Investment Fund, via fund manager The FSE Group.